Dobutamine Infusion Rate Calculation
To calculate the infusion rate in mL/h for a dobutamine drip, use the formula: mL/h = (dose in µg/kg/min × weight in kg × 60 min/h) ÷ concentration in µg/mL. For a 70-kg adult at 5 µg/kg/min using a standard 1,000 µg/mL concentration, this equals 21 mL/h.
Standard Dosing Parameters
Start dobutamine at 0.5–1.0 µg/kg/min and titrate upward based on clinical response 1. The FDA-approved dosing range is typically 2–20 µg/kg/min, though doses up to 40 µg/kg/min have occasionally been required 1.
Initial Dosing by Clinical Context
Acute heart failure with hypoperfusion: Start at 2.5 µg/kg/min, doubling every 15 minutes according to response (limited by tachycardia, arrhythmias, or ischemia); doses >20 µg/kg/min rarely needed 2
Post-cardiac arrest myocardial dysfunction: Optimal dose is 5 µg/kg/min for restoring systolic and diastolic function without adversely affecting myocardial oxygen consumption 3
Pharmacological stress testing: Start at 5–10 µg/kg/min, increasing by 10 µg/kg/min every 3 minutes to a maximum of 40–50 µg/kg/min 4
Standard Concentration Preparations
The FDA label provides infusion rate tables for three standard concentrations 1:
- 500 µg/mL: For a 70-kg patient at 5 µg/kg/min = 42 mL/h
- 1,000 µg/mL: For a 70-kg patient at 5 µg/kg/min = 21 mL/h
- 2,000 µg/mL: For a 70-kg patient at 5 µg/kg/min = 10.5 mL/h
Concentrations up to 5,000 µg/mL have been safely administered (250 mg/50 mL), with final volume determined by patient fluid requirements 1.
Practical Calculation Steps
- Determine target dose (µg/kg/min) based on clinical indication
- Calculate total µg/min needed: dose × patient weight in kg
- Convert to µg/h: multiply by 60
- Divide by concentration (µg/mL) to get mL/h
Example for 70-kg Adult at 5 µg/kg/min with 1,000 µg/mL Concentration:
- 5 µg/kg/min × 70 kg = 350 µg/min
- 350 µg/min × 60 = 21,000 µg/h
- 21,000 µg/h ÷ 1,000 µg/mL = 21 mL/h
Titration Guidelines
Monitor continuously during titration: systemic blood pressure, urine flow, ectopic activity frequency, heart rate, and when possible cardiac output, central venous pressure, and pulmonary capillary wedge pressure 1.
Dose escalation intervals: Increase every 5–15 minutes depending on clinical context 2, 5. In acute heart failure, doubling the dose every 15 minutes is appropriate 2. For stress testing, 3-minute intervals are standard 4.
Weaning: Gradual tapering by 2 µg/kg/min decrements with simultaneous optimization of oral therapy is essential to prevent rebound deterioration 5.
Critical Monitoring Parameters
- Tachycardia is the most common dose-limiting factor
- Arrhythmias (both atrial and ventricular) require continuous ECG telemetry 5
- Hypotension may occur despite inotropic effects, particularly in patients with low systemic vascular resistance 2
- Myocardial ischemia manifests as new wall motion abnormalities or angina
Common Pitfalls
In patients on beta-blockers, dobutamine doses may need to increase to 20 µg/kg/min to restore inotropic effect 5. The beta-blockade reduces dobutamine's efficacy, requiring higher doses to achieve the same hemodynamic response.
Avoid mixing with alkaline solutions (5% Sodium Bicarbonate) or other drugs in the same solution due to physical incompatibilities 1. Do not use with agents containing both sodium bisulfite and ethanol 1.
Stability: Diluted solutions must be used within 24 hours 1.